Phospholipid-dependent PKC activities and levels decrease in leukocytes and platelets of AD patients compared with the controls (Bosman et al., 1992; Lanius et al., 1997; Matsushima et al., 1994; Molchan et al., 1993). The gene discussed is PRRT2; the disease is Alzheimer disease.